Windlas Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Mar ' 21

Sales

297.46

252.67

239.72

226.21

224.00

Operating profit

35.83

29.85

27.36

25.54

28.49

Interest

0.52

0.47

0.50

0.92

0.73

Gross profit

41.17

34.86

31.65

26.53

29.54

EPS (Rs)

12.55

10.10

10.82

6.88

14.17

Other income

5.86

5.47

4.80

1.91

1.78

Stock adjustment

7.32

-13.99

-2.73

-2.01

-3.33

Raw material

6.33

174.84

159.17

148.39

147.49

Power and fuel

-

-

-

-

-

Employee expenses

41.88

34.35

32.25

31.16

31.15

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

206.11

27.62

23.69

23.13

20.20

Provisions made

-

-

-

-

-

Depreciation

6.52

5.66

6.05

6.10

6.70

Taxation

8.56

7.19

2.03

5.44

4.67

Net profit / loss

26.10

22.01

23.57

14.99

18.17

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.40

10.90

10.90

10.90

6.41

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

12.05

11.81

11.41

11.29

12.72

GPM (%)

13.57

13.50

12.95

11.63

13.08

NPM (%)

8.60

8.53

9.64

6.57

8.05